|
Orthologous residues
|
|
VASP (human): S157‑p, VASP (mouse): S153‑p, VASP (rat): S154‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
electrophoretic mobility shift, mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
CV1 (fibroblast) [PKG1 iso2 (mouse)], CV1 (fibroblast) [VASP (mouse)]
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
PKG1 iso2 (mouse)
|
transfection of constitutively active enzyme, co-immunoprecipitation
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
cGMP analog
|
|
|
|
increase
|
|
|